Atlas Trials

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Clinical trial NCT06779773 · RECRUITING

Trial details

NCT number
NCT06779773
Sponsor
Astellas Pharma Global Development, Inc.
Status
RECRUITING
Study type
OBSERVATIONAL
Geographic AtrophyMacular Degeneration
Start date
2025-01-22
Primary completion
2030-10-31
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.